Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michelle Haber

Showing results (21-30 of 186) with videos related to

Pageof 19
Sort By:
Pharmacogenetics and Genomics|August 19, 2007
Polymorphisms in genes encoding drug metabolizing enzymes and their influence on the outcome of children with neuroblastomaLesley J Ashton, Jayne E Murray, Michelle Haber, et al.
Nature Reviews. Cancer|April 11, 2018
Too many targets, not enough patients: rethinking neuroblastoma clinical trialsJamie I Fletcher, David S Ziegler, Toby N Trahair, et al.
Molecular Cancer|October 26, 2007
Enhancing the anti-angiogenic action of histone deacetylase inhibitorsSelena Kuljaca, Tao Liu, Andrew E L Tee, et al.
Blood Cells, Molecules & Diseases|December 17, 2002
Genomic imbalances in drug-resistant T-cell acute lymphoblastic CEM leukemia cell linesThomas Efferth, Irmgard Verdorfer, Hayato Miyachi, et al.
Cell Death & Disease|January 24, 2019
Transcriptome profiling of caspase-2 deficient EμMyc and Th-MYCN mouse tumors identifies distinct putative roles for caspase-2 in neuronal differentiation and immune signalingLoretta Dorstyn, Emily Hackett-Jones, Andrej Nikolic, et al.
Frontiers in Oncology|November 28, 2012
Polyamine pathway inhibition as a novel therapeutic approach to treating neuroblastomaLaura D Gamble, Michael D Hogarty, Xueyuan Liu, et al.
Journal of Medicinal Chemistry|October 1, 2009
Optimization of the antitumor efficacy of a synthetic mitochondrial toxin by increasing the residence time in the cytosolPierre J Dilda, Stéphanie Decollogne, Lakmini Weerakoon, et al.
Cancer Letters|July 26, 2003
The p53 pathway and its inactivation in neuroblastomaDeborah A Tweddle, Andrew D J Pearson, Michelle Haber, et al.
The Journal of Clinical Investigation|June 16, 2020
Immune profiling of pediatric solid tumorsRachael L Terry, Deborah Meyran, David S Ziegler, et al.
Apoptosis : an International Journal on Programmed Cell Death|February 14, 2013
TRIM16 overexpression induces apoptosis through activation of caspase-2 in cancer cellsPatrick Y Kim, Aldwin Suryo Rahmanto, Owen Tan, et al.
Pageof 19

Showing results (21-30 of 186) with videos related to

Sort By:
Pageof 19
Pharmacogenetics and Genomics|August 19, 2007
Polymorphisms in genes encoding drug metabolizing enzymes and their influence on the outcome of children with neuroblastomaLesley J Ashton, Jayne E Murray, Michelle Haber, et al.
Nature Reviews. Cancer|April 11, 2018
Too many targets, not enough patients: rethinking neuroblastoma clinical trialsJamie I Fletcher, David S Ziegler, Toby N Trahair, et al.
Molecular Cancer|October 26, 2007
Enhancing the anti-angiogenic action of histone deacetylase inhibitorsSelena Kuljaca, Tao Liu, Andrew E L Tee, et al.
Blood Cells, Molecules & Diseases|December 17, 2002
Genomic imbalances in drug-resistant T-cell acute lymphoblastic CEM leukemia cell linesThomas Efferth, Irmgard Verdorfer, Hayato Miyachi, et al.
Cell Death & Disease|January 24, 2019
Transcriptome profiling of caspase-2 deficient EμMyc and Th-MYCN mouse tumors identifies distinct putative roles for caspase-2 in neuronal differentiation and immune signalingLoretta Dorstyn, Emily Hackett-Jones, Andrej Nikolic, et al.
Frontiers in Oncology|November 28, 2012
Polyamine pathway inhibition as a novel therapeutic approach to treating neuroblastomaLaura D Gamble, Michael D Hogarty, Xueyuan Liu, et al.
Journal of Medicinal Chemistry|October 1, 2009
Optimization of the antitumor efficacy of a synthetic mitochondrial toxin by increasing the residence time in the cytosolPierre J Dilda, Stéphanie Decollogne, Lakmini Weerakoon, et al.
Cancer Letters|July 26, 2003
The p53 pathway and its inactivation in neuroblastomaDeborah A Tweddle, Andrew D J Pearson, Michelle Haber, et al.
The Journal of Clinical Investigation|June 16, 2020
Immune profiling of pediatric solid tumorsRachael L Terry, Deborah Meyran, David S Ziegler, et al.
Apoptosis : an International Journal on Programmed Cell Death|February 14, 2013
TRIM16 overexpression induces apoptosis through activation of caspase-2 in cancer cellsPatrick Y Kim, Aldwin Suryo Rahmanto, Owen Tan, et al.
Pageof 19